Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety of DP-R207 vs Rosuvastatin in Primary Hypercholesterolemia
NCT02445352Phase 3Completed
- Sponsor
- Alvogen
- Start
- Jul 2014
- Primary completion
- Jan 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ezetimibe + rosuvastatin in hypercholesterolemia, sponsored by Alvogen. Started Jul 2014; status: completed.
02
Drugs
ezetimibe + rosuvastatin
03
Conditions
hypercholesterolemia
Beyond the preview
Go deeper on NCT02445352.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02445352.